Viewing Study NCT05669833


Ignite Creation Date: 2025-12-25 @ 2:50 AM
Ignite Modification Date: 2025-12-30 @ 8:30 PM
Study NCT ID: NCT05669833
Status: RECRUITING
Last Update Posted: 2025-10-09
First Post: 2022-12-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients
Sponsor: University of Pennsylvania
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module